26.06.2014 • News
Merck
17.06.2014 • News
Merck Agrees Sale of Chemische Fabrik Lehrte
13.06.2014 • News
Merck KGaA and MorphoSys in Joint Antibody R&D
13.05.2014 • News
Marcus Kuhnert Named CFO of Merck KGaA
02.05.2014 • News
Merck Receives Final Antitrust Clearance for AZ
29.04.2014 • News
Total Says LNG Unit Not Now for Sale
23.04.2014 • News
Novartis and Lilly Clinch Animal Health Deal
07.04.2014 • News
Merck Serono Gains Rights to Market EEVA Test
02.04.2014 • News
Matthias Zachert Steps in as Lanxess CEO
17.03.2014 • News
Germany’s Merck Extends AZ Offer a Fifth Time
27.02.2014 • News
Lanxess Expects Net Loss for Full Year 2013
13.02.2014 • News
Reckitt Benckiser Says Pharma Review Ongoing
ARC Advisory Group GmbH & Co KG
LANXESS Deutschland GmbH
Codexis
Iktos AI
Sartorius AG
CHEManager c/o Wiley-VCH Verlag GmbH & Co. KGaA
EvaluatePharma
SchüllerConsulting
Thomson Reuters
KPMG
Univers. St. Gallen
Datamonitor Group
Frost & Sullivan
CHEManager International c/o Wiley-VCH GmbH
Merck & Co
Evotec
PP Consulting
Merck KGaA
ISPE D/A/CH e.V.
Merck Chemicals Co. Ltd.
Arthur D. Little
Mack Brooks Exhibition Ltd – Part of RX
Millipore Corporation
Together for Sustanability (TFS)